INHIBITORS OF TRANSPEPTIDASE
    1.
    发明申请
    INHIBITORS OF TRANSPEPTIDASE 审中-公开
    运输抑制剂

    公开(公告)号:WO1982001875A1

    公开(公告)日:1982-06-10

    申请号:PCT/US1981000109

    申请日:1981-01-19

    Applicant: ABBOTT LAB

    CPC classification number: C07D477/24

    Abstract: New ss-lactams of the general structure: (FORMULA) wherein R represents H or an acyl moiety known from the penicillin or cephalosporin art, R' is hydrogen, lower alkoxy, lower alkoxyalkyl, lower alkyl, phenylthio or lower alkylmercapto, R' is lower alkyl, the broken line represents an optional double bond, and acyloxymethyl esters thereof. All compounds are effective antibacterials.

    Abstract translation: 一般结构的新型β-内酰胺:其中R表示H或由青霉素或头孢菌素领域已知的酰基部分,其中R'为氢,低级烷氧基,低级烷氧基烷基,低级烷基,苯硫基或低级烷基巯基,R'为 低级烷基,虚线表示任选的双键,和其酰氧基甲基酯。 所有化合物都是有效的抗菌剂。

    MIXED SALT OF VALPROIC ACID
    2.
    发明申请
    MIXED SALT OF VALPROIC ACID 审中-公开
    混合酸的盐酸盐

    公开(公告)号:WO1981000562A1

    公开(公告)日:1981-03-05

    申请号:PCT/US1980000954

    申请日:1980-07-28

    Applicant: ABBOTT LAB

    Inventor: ABBOTT LAB MEADE E

    CPC classification number: C07C53/128

    Abstract: Certain diethyl- or dipropylacetic acid salts of sodium or calcium valproate which have physiological properties similar to those of valproic acid or sodium valproate but show highly superior stability characteristics.

    Abstract translation: 某些具有与丙戊酸或丙戊酸钠类似的生理特性的丙戊酸钠或钙的二乙基或二丙基乙酸盐,但显示出非常优异的稳定性。

    NOVEL VALVE EMPLOYING HYDROPHOBIC AND HYDROPHILIC MEMBRANES
    3.
    发明申请
    NOVEL VALVE EMPLOYING HYDROPHOBIC AND HYDROPHILIC MEMBRANES 审中-公开
    使用疏水性和疏水性膜的新型阀

    公开(公告)号:WO1980001754A1

    公开(公告)日:1980-09-04

    申请号:PCT/US1980000071

    申请日:1980-01-23

    Applicant: ABBOTT LAB

    CPC classification number: A61M5/1408 A61M5/36 B01D19/0031

    Abstract: Gravitational flow system and equipment sets for the sequential administration of medical liquids wherein a primary liquid from a first source (11) can be administered at a flow rate independent of the flow rate of secondary liquid in a second source (13). A combined air barrier and liquid sequencing valve chamber (32) controls the sequencing of the various flows and prevents inadvertent administration of air when the second source is depleted by means of a hydrophilic barrier (45). The valve chamber (32) is divided into two separate flow chambers (34, 41) which are in liquid communication with the respective sources (11, 13) and in air communication therebetween by means of hydrophobic membrane (53).

    IMPROVED RADIOPAQUE MEDICAL TUBING
    4.
    发明申请
    IMPROVED RADIOPAQUE MEDICAL TUBING 审中-公开
    改进无线电医疗管道

    公开(公告)号:WO1982000413A1

    公开(公告)日:1982-02-18

    申请号:PCT/US1981000846

    申请日:1981-06-19

    Applicant: ABBOTT LAB

    CPC classification number: A61M25/0108

    Abstract: An improved coextruded tubing (12) composition comprises a physiologically inert flexible waterproof thermoplastic material having encapsulated within the wall (14) of tubing (12) one or more strips (16) of radiopaque material coaxially disposed along the length of tubing.

    Abstract translation: 改进的共挤出管(12)组合物包括生理惰性的柔性防水热塑性材料,其包封在管(12)的壁(14)内,沿着管的长度同轴设置的一个或多个不透射线材料条(16)。

    EQUIPMENT SETS AND SYSTEMS FOR THE SEQUENTIAL ADMINISTRATION OF MEDICAL LIQUIDS AT DUAL FLOW RATES
    5.
    发明申请
    EQUIPMENT SETS AND SYSTEMS FOR THE SEQUENTIAL ADMINISTRATION OF MEDICAL LIQUIDS AT DUAL FLOW RATES 审中-公开
    医疗液体在双流量下的顺序管理的设备组和系统

    公开(公告)号:WO1980001756A1

    公开(公告)日:1980-09-04

    申请号:PCT/US1980000070

    申请日:1980-01-23

    Applicant: ABBOTT LAB

    CPC classification number: A61M5/36 A61M5/1408

    Abstract: Gravitational flow systems and equipment sets for the sequential administration of medical liquids wherein a primary source (11) can be administered at a flow rate independent of the flow rate of a secondary source (13) and including a barrier (47) substantially impervious to air to prevent the inadvertent administration of air when the secondary source (13) is depleted. The air barrier may consist of either a hydrophilic membrane (45) or mechanical float valve (65) or a diaphragm operated barrier member (241).

    Abstract translation: 用于顺序施用医用液体的重力流系统和设备组,其中主要源(11)可以以独立于次级源(13)的流速的流速施用并且包括基本上不渗透空气的屏障(47) 以防止在二次源(13)耗尽时无意中的空气管理。 空气屏障可以由亲水膜(45)或机械浮阀(65)或隔膜操作的阻挡构件(241)组成。

Patent Agency Ranking